TNFRSF17 and plasma cell myeloma: One mechanism of antigen downregulation is reversible antigen loss, mostly due to heterogeneity of target expression that enables expansion of pre-existing minor myeloma cell populations with lower expression of BCMA and/or CD38 (refs. 19,49,50).